In this article, we present developments in NK cell adoptive immunotherapy for hematologic and solid tumor malignancies.

"These genetically modified NK cells offer a great treatment opportunity for patients with solid tumors that are currently resistant to immunotherapy," explains Dr. Clara Montagut, researcher at ...

The genetic modification of the Natural Killer (NK) cells, lymphocytes forming part of the body’s immune system, would make it possible to retain their capacity of eliminating tumour cells in solid ...

A team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells ...

Coeptis Inc. (Nasdaq: COEP) has taken a bold step forward in the fight against cancer by securing exclusive worldwide development and commercialization rights to the groundbreakin ...

Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune ...

Continues focus on development of bispecific anti-cancer agents with differentiated mechanisms of action SEATTLE, WASHINGTON / ACCESS Newswire / March 18, 2025 / Aptevo Therapeutics (NASDAQ:APVO), a ...

Immunotherapy is a type of cancer treatment that helps your immune system detect and fight cancer cells. Treatments may be administered via a catheter, intravenously, or by injection. There are ...

If you have advanced kidney cancer, also known as metastatic renal cell carcinoma, your doctor may suggest you try immunotherapy. It helps some people with the disease live longer. Though there ...

Alloreactive NK cells can be delivered either as adoptive immunotherapy or within the context of hematopoietic cell transplantation (HCT). There are three methods from which NK cell products for ...